258 related articles for article (PubMed ID: 21940710)
1. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
[TBL] [Abstract][Full Text] [Related]
2. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
3. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
4. High-throughput assays for promiscuous inhibitors.
Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
[TBL] [Abstract][Full Text] [Related]
5. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
Martin E; Mukherjee P; Sullivan D; Jansen J
J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
[TBL] [Abstract][Full Text] [Related]
6. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
Shun TY; Lazo JS; Sharlow ER; Johnston PA
J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
Heeres JT; Hergenrother PJ
Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
[TBL] [Abstract][Full Text] [Related]
8. Enhanced HTS hit selection via a local hit rate analysis.
Posner BA; Xi H; Mills JE
J Chem Inf Model; 2009 Oct; 49(10):2202-10. PubMed ID: 19795815
[TBL] [Abstract][Full Text] [Related]
9. Multiplex enzyme assays and inhibitor screening by mass spectrometry.
Rathore R; Pribil P; Corr JJ; Seibel WL; Evdokimov A; Greis KD
J Biomol Screen; 2010 Sep; 15(8):1001-7. PubMed ID: 20228278
[TBL] [Abstract][Full Text] [Related]
10. Comparison of compound administration methods in biochemical assays: effects on apparent compound potency using either assay-ready compound plates or pin tool-delivered compounds.
Smith T; Ho PI; Yue K; Itkin Z; MacDougall D; Paolucci M; Hill A; Auld DS
J Biomol Screen; 2013 Jan; 18(1):14-25. PubMed ID: 22904199
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
12. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
[TBL] [Abstract][Full Text] [Related]
13. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
Ilouga PE; Hesterkamp T
J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
Jenkins JL; Kao RY; Shapiro R
Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601
[TBL] [Abstract][Full Text] [Related]
15. The design, annotation, and application of a kinase-targeted library.
Xi H; Lunney EA
Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
[TBL] [Abstract][Full Text] [Related]
16. Biodiversity of small molecules--a new perspective in screening set selection.
Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
[TBL] [Abstract][Full Text] [Related]
17. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
[TBL] [Abstract][Full Text] [Related]
18. Which aspects of HTS are empirically correlated with downstream success?
Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
[TBL] [Abstract][Full Text] [Related]
19. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis testing in high-throughput screening for drug discovery.
Prummer M
J Biomol Screen; 2012 Apr; 17(4):519-29. PubMed ID: 22233646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
